Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.08 - $21.0 $52,541 - $13.8 Million
656,770 Added 32.27%
2,692,183 $163,000
Q2 2022

Aug 15, 2022

BUY
$0.16 - $0.47 $296,022 - $869,564
1,850,138 Added 998.59%
2,035,413 $342,000
Q1 2022

May 16, 2022

BUY
$0.42 - $0.62 $49,711 - $73,383
118,360 Added 176.88%
185,275 $87,000
Q4 2021

Feb 14, 2022

BUY
$0.56 - $1.71 $37,472 - $114,424
66,915 New
66,915 $38,000
Q2 2021

Aug 16, 2021

SELL
$1.56 - $1.98 $2.98 Million - $3.78 Million
-1,910,256 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$1.36 - $2.49 $2.23 Million - $4.08 Million
1,637,386 Added 600.06%
1,910,256 $3.23 Million
Q4 2020

Feb 16, 2021

BUY
$0.75 - $2.76 $197,003 - $724,971
262,671 Added 2575.46%
272,870 $434,000
Q3 2020

Nov 16, 2020

BUY
$0.61 - $1.17 $6,221 - $11,932
10,199 New
10,199 $10,000
Q1 2020

May 14, 2020

SELL
$0.36 - $0.74 $22,976 - $47,229
-63,823 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$0.35 - $0.58 $29,999 - $49,714
-85,714 Reduced 57.32%
63,823 $37,000
Q3 2019

Nov 14, 2019

SELL
$0.38 - $0.52 $664,172 - $908,867
-1,747,823 Reduced 92.12%
149,537 $74,000
Q2 2019

Aug 15, 2019

BUY
$0.39 - $0.7 $721,002 - $1.29 Million
1,848,725 Added 3801.22%
1,897,360 $736,000
Q2 2019

Aug 14, 2019

BUY
$0.39 - $0.7 $18,967 - $34,044
48,635 New
48,635 $690,000
Q2 2018

Aug 14, 2018

SELL
$1.66 - $3.82 $1.3 Million - $2.99 Million
-782,407 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.16 - $3.48 $1.29 Million - $2.08 Million
597,001 Added 322.0%
782,407 $2.66 Million
Q4 2017

Feb 14, 2018

SELL
$0.68 - $4.19 $115,372 - $710,896
-169,665 Reduced 47.78%
185,406 $755,000
Q3 2017

Nov 14, 2017

BUY
$0.38 - $0.66 $134,926 - $234,346
355,071
355,071 $217,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.